drugset / Trial / NCT00824317
Stimulant Drug Treatment of Attention-Deficit Hyperactivity Disorder (AD/HD), Inattentive Type
Completed
25 enrolled
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH) · collab
CrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to compare the response to methylphenidate treatment of children with two different subtypes of ADHD.
Timeline
- Start
- 2001-10
- Primary completion
- 2005-02
- Completion
- 2005-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylphenidate | Small molecule | 15 mg | — |
| Subject | Methylphenidate | Small molecule | 25 mg | — |
| Subject | Methylphenidate | Small molecule | 40 mg | — |